AstraZeneca Pays $520 Million to Settle Seroquel Whistleblower Claims

AstraZeneca Pays $520 Million to Settle Seroquel Whistleblower Claims Kenney & McCafferty Represent Whistleblower Dr. Stefan Kruszewski (PRWEB) April 28, 2010 -- AstraZeneca has agreed to pay $520 million in civil fines, penalties and damages to settle allegations that the company defrauded Medicare, Medicaid and other government-funded health care programs in connection with its marketing and promotional practices for the blockbuster atypical antipsychotic Seroquel (U.S. ex rel. STEFAN KRUSZEWSKI, MD v. ASTRAZENECA PHARMACEUTICALS, LP., Eas
Contributor
About
PRWeb, a leader in online news and press release distribution, has been used by attorneys, law firms and more than 40,000 organizations